(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid | CAS:909122-50-5

We serve (3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid CAS:909122-50-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid

Product Name: (3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid
Other Name: 
(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid
3-chloro-4-ethoxy-2-fluorophenylboronic acid
CAS No: 909122-50-5
MF: C8H9BClFO3
MW: 218.41800
Density: 1.3±0.1 g/cm3
Boiling point: 342.8±52.0 °C at 760 mmHg
Melting point: N/A
Flash point: 161.1±30.7 °C
Refractive index: 1.520
UN Number: N/A
Transport hazard class: N/A
Packing group: N/A
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like (3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-4-ethoxy-2-fluorophenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid Use and application,(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.DL-Norleucine manufacturer DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.Ethyl (1E)-N-cyanoethanimidate supplier DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.(S)-Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate vendor Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.